Coughlin Steven S
Self, Memphis, TN, United States.
JMIR Res Protoc. 2015 Feb 6;4(1):e13. doi: 10.2196/resprot.3822.
Improved drugs have been approved for the treatment of hepatitis C virus (HCV), but many people are unaware of improved therapies that are now available to cure the illness in a high percentage of patients.
The objectives of the Test, Listen, Cure (TLC) Hepatitis C Community Awareness Campaign include the development and implementation of a health education and promotion campaign in Memphis, Tennessee, and surrounding areas of western Tennessee, eastern Arkansas, and northern Mississippi, to increase community awareness about HCV, and to provide up-to-date provider education on HCV screening and treatment. The health education and promotion campaign, which will be conducted in collaboration with area hospitals, clinics, and nonprofit organizations, will provide information about how HCV infection is transmitted, risk factors for the disease, the importance of screening and treatment, and the availability of improved treatment for the disease. A second objective will be to provide continuing professional education on HCV screening and treatment to a minimum of 200 area health care providers, including primary care and internal medicine physicians and residents, physician assistants, nurse practitioners, providers who care for homeless persons, and dialysis unit nurses.
Health education materials will be developed for this community awareness campaign that is culturally appropriate for African Americans and suitable for people with lower health literacy and educational attainment. Information will be compiled and disseminated about area providers who provide screening services and treatment for persons with HCV in order to facilitate linkages to care. Four focus groups of 8-10, African American adults aged 40-64, will be conducted to test the health education materials. The provider education on HCV will also address patient-physician communication and cultural competency. The National Medical Association regional chapters and expert physician consultants will provide assistance with delivering the education program.
Results from this one year project will be available in early 2016.
Depending on the availability of funding and successful implementation of the project, the TLC campaign will be extended to similar cities in the United States.
已有改良药物获批用于治疗丙型肝炎病毒(HCV),但许多人并不知晓现在有改良疗法可使高比例患者治愈该疾病。
“检测、倾听、治愈”(TLC)丙型肝炎社区宣传活动的目标包括在田纳西州孟菲斯市以及田纳西州西部、阿肯色州东部和密西西比州北部周边地区开展并实施一场健康教育与推广活动,以提高社区对HCV的认识,并为医疗服务提供者提供关于HCV筛查和治疗的最新教育。这场将与地区医院、诊所及非营利组织合作开展的健康教育与推广活动,将提供有关HCV感染传播方式、该疾病的风险因素、筛查和治疗的重要性以及该疾病改良治疗方法可及性的信息。第二个目标是为至少200名地区医疗服务提供者提供关于HCV筛查和治疗的继续专业教育,这些提供者包括初级保健医生、内科医生及其住院医师、医师助理、执业护士、照顾无家可归者的医护人员以及透析科室护士。
将为此次社区宣传活动编写适合非裔美国人文化且适用于健康素养和教育程度较低人群的健康教育材料。将汇编并传播有关为HCV患者提供筛查服务和治疗的地区医疗服务提供者的信息,以促进获得医疗服务。将开展4个由8 - 10名年龄在40 - 64岁的非裔美国成年人组成的焦点小组,以测试这些健康教育材料。关于HCV的医疗服务提供者教育还将涉及医患沟通和文化能力。美国国家医学协会地区分会和专家医生顾问将协助开展教育项目。
这个为期一年的项目结果将于2016年初可得。
根据资金可得情况以及项目的成功实施情况,TLC活动将扩展至美国其他类似城市。